[Form 4] VeriSign Inc Insider Trading Activity

Rhea-AI Filing Summary

VeriSign insider sales by CEO D. James Bidzos: Between September 9-11, 2025 the reporting person sold a total of 9,000 shares of VeriSign common stock in multiple transactions at prices ranging approximately from $280.51 to $289.55. The transactions were reported as made pursuant to a written Rule 10b5-1 plan (box checked). The filing notes inclusion of 134.7365 dividend-equivalent restricted stock units acquired August 27, 2025, in respect of previously granted restricted stock units. Following these reported sales, the reporting person’s beneficial ownership is shown as 485,438.7009 shares. The form is a standard Section 16 disclosure of insider sales with weighted-average prices and ranges disclosed for multi-price trades.

Positive

• Transactions were made pursuant to a written Rule 10b5-1 plan, indicating pre-scheduled, documented sales.
• Filing discloses dividend-equivalent RSUs (134.7365 shares) acquired Aug 27, 2025, showing the form includes compensatory adjustments.

Negative

• None.

Insights

Financial Analyst

TL;DR: CEO executed planned, disclosed sales totaling 9,000 shares over three days; ownership remains substantial.

The sales total 9,000 shares executed across 9/9–9/11/2025 at per-share prices reported in specified weighted-average ranges from about $280.51 to $289.55. The report explicitly indicates the transactions were made under a written Rule 10b5-1 plan, which typically schedules sales regardless of short-term company developments. Post-transactions beneficial ownership is 485,438.7009 shares, reflecting a modest reduction relative to prior holdings; the filing also records 134.7365 dividend-equivalent RSUs acquired Aug 27, 2025. From a financial-materiality perspective, these appear routine and fully disclosed rather than an unexpected corporate event.

Corporate Governance Expert

TL;DR: Proper Section 16 disclosure and 10b5-1 plan checkbox indicate procedural compliance with insider trading rules.

The Form 4 is executed and signed by power of attorney, lists the reporting person’s roles (Exec. Chairman, President & CEO), and checks the box indicating sales pursuant to a 10b5-1 written plan. The filing provides weighted-average prices and ranges for multi-price trades and documents recent dividend-equivalent RSU acquisition. Governance-wise, the form demonstrates transparent reporting and adherence to required insider-trading disclosure formats; no indications of corrective amendments or missing mandatory details are present in the submitted text.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BIDZOS D JAMES

(Last) (First) (Middle)

12061 BLUEMONT WAY

(Street)

RESTON VA 20190

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERISIGN INC/CA [ VRSN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Exec. Chairman, Pres, & CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2025		S		1,250	D	$280.8236(1)	493,188.7009(2)	D
Common Stock	09/09/2025		S		950	D	$282.2756(3)	492,238.7009	D
Common Stock	09/09/2025		S		764	D	$283.113(4)	491,474.7009	D
Common Stock	09/09/2025		S		600	D	$284.1075(5)	490,874.7009	D
Common Stock	09/09/2025		S		1,436	D	$285.6795(6)	489,438.7009	D
Common Stock	09/10/2025		S		1,600	D	$283.4145(7)	487,838.7009	D
Common Stock	09/10/2025		S		200	D	$284.88(8)	487,638.7009	D
Common Stock	09/10/2025		S		200	D	$286.46	487,438.7009	D
Common Stock	09/11/2025		S		200	D	$284.77	487,238.7009	D
Common Stock	09/11/2025		S		400	D	$286.68(9)	486,838.7009	D
Common Stock	09/11/2025		S		845	D	$287.756(10)	485,993.7009	D
Common Stock	09/11/2025		S		455	D	$289.1185(11)	485,538.7009	D
Common Stock	09/11/2025		S		100	D	$290.18	485,438.7009	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $280.51 to $281.41, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

2. Includes 134.7365 dividend equivalent restricted stock units acquired on August 27, 2025, in respect of previously granted restricted stock units under the Company's Amended and Restated 2006 Equity Incentive Plan.

3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $281.61 to $282.53, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

4. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $282.69 to $283.64, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

5. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $283.78 to $284.20, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

6. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $284.92 to $285.86, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

7. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $283.06 to $283.76, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

8. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $284.41 to $285.35, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

9. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $286.02 to $286.97, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

10. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $287.26 to $288.21, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

11. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $288.63 to $289.55, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Remarks:

	Thomas C. Indelicarto by Power of Attorney for D. James Bidzos	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did the Form 4 for VRSN report?

The Form 4 reports that D. James Bidzos sold a total of 9,000 shares of VeriSign (VRSN) between September 9 and 11, 2025.

Were these sales disclosed as part of a 10b5-1 plan on the VRSN Form 4?

Yes. The filer checked the box indicating the transactions were made pursuant to a written Rule 10b5-1 plan.

What price range is reported for the VeriSign share sales?

The filing shows transaction price ranges across the trades of approximately $280.51 to $289.55 per share, with weighted-average prices reported per line.

How many shares does the reporting person own after these transactions?

Following the reported sales the filing shows beneficial ownership of 485,438.7009 shares.

Does the Form 4 disclose any recent equity awards or RSUs for the reporting person?

Yes. The filing includes 134.7365 dividend-equivalent restricted stock units acquired on August 27, 2025 in respect of previously granted restricted stock units.